Clinical and pharmacophenomic study demonstrates effective treatment in refractory Rosai-Dorfman-Destombes disease, suggesting improved patient outcomes.
A combined clinical and computational pharmacophenomic study from the Coastal Rare Inflammatory Diseases Program and Every Cure.
No takes yet. Share an insight, caveat, or question.
Leung et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: